CL2016000836A1 - Composiciones de péptidos nuevas. - Google Patents

Composiciones de péptidos nuevas.

Info

Publication number
CL2016000836A1
CL2016000836A1 CL2016000836A CL2016000836A CL2016000836A1 CL 2016000836 A1 CL2016000836 A1 CL 2016000836A1 CL 2016000836 A CL2016000836 A CL 2016000836A CL 2016000836 A CL2016000836 A CL 2016000836A CL 2016000836 A1 CL2016000836 A1 CL 2016000836A1
Authority
CL
Chile
Prior art keywords
peptide compositions
new peptide
new
compositions
peptide
Prior art date
Application number
CL2016000836A
Other languages
English (en)
Spanish (es)
Inventor
Richard Franklin
Original Assignee
Tarix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarix Pharmaceuticals Ltd filed Critical Tarix Pharmaceuticals Ltd
Publication of CL2016000836A1 publication Critical patent/CL2016000836A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CL2016000836A 2013-10-11 2016-04-11 Composiciones de péptidos nuevas. CL2016000836A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US201461940095P 2014-02-14 2014-02-14

Publications (1)

Publication Number Publication Date
CL2016000836A1 true CL2016000836A1 (es) 2016-09-16

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000836A CL2016000836A1 (es) 2013-10-11 2016-04-11 Composiciones de péptidos nuevas.

Country Status (13)

Country Link
EP (1) EP3054967A4 (enExample)
JP (1) JP2017501967A (enExample)
KR (1) KR20160065969A (enExample)
CN (1) CN105828831A (enExample)
AU (1) AU2014332346B2 (enExample)
BR (1) BR112016007816A2 (enExample)
CA (1) CA2926641A1 (enExample)
CL (1) CL2016000836A1 (enExample)
IL (1) IL244956B (enExample)
MX (1) MX2016004660A (enExample)
RU (1) RU2016112931A (enExample)
SG (1) SG11201602661PA (enExample)
WO (1) WO2015054006A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6863362B2 (ja) * 2016-03-03 2021-04-21 不二製油株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物
EA201991699A1 (ru) * 2017-02-16 2020-01-21 Кареджен Ко., Лтд. Конъюгат салициловой кислоты и пептида

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
DE69738326T2 (de) 1996-07-12 2008-07-03 Mcgill University, Montreal Verbindungen und verfahren zur regulierung der zellanlagerung
WO2001053331A2 (en) 2000-01-24 2001-07-26 Adherex Technologies, Inc. Peptidomimetic modulators of cell adhesion
AU2002335657A1 (en) 2001-08-24 2003-03-10 Neuronz Biosciences, Inc. Neural regeneration peptide and methods for their use in treatment of brain damage
US7563862B2 (en) 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
AU2003293807A1 (en) * 2002-12-24 2004-07-22 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
EP1685151A4 (en) * 2003-10-31 2009-04-22 Neuren Pharmaceuticals Ltd PEPTIDES FOR THE REGENERATION OF NERVES AND METHOD FOR THEIR APPLICATION IN THE TREATMENT OF BRAIN DAMAGES
WO2007011595A2 (en) 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
WO2012006598A2 (en) * 2010-07-09 2012-01-12 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
KR20140140546A (ko) * 2012-02-10 2014-12-09 타릭스 파마슈티컬스 엘티디. 말초 혈관 질환의 치료를 위한 조성물 및 방법

Also Published As

Publication number Publication date
CN105828831A (zh) 2016-08-03
IL244956B (en) 2019-10-31
SG11201602661PA (en) 2016-05-30
KR20160065969A (ko) 2016-06-09
EP3054967A4 (en) 2017-04-19
BR112016007816A2 (pt) 2017-12-05
WO2015054006A2 (en) 2015-04-16
AU2014332346B2 (en) 2019-01-24
CA2926641A1 (en) 2015-04-16
MX2016004660A (es) 2016-11-14
EP3054967A2 (en) 2016-08-17
WO2015054006A3 (en) 2015-06-04
JP2017501967A (ja) 2017-01-19
AU2014332346A1 (en) 2016-05-05
IL244956A0 (en) 2016-05-31
RU2016112931A (ru) 2017-11-16
RU2016112931A3 (enExample) 2018-06-20

Similar Documents

Publication Publication Date Title
CL2016000258A1 (es) Composiciones edulcorantes.
CL2016000257A1 (es) Composiciones edulcorantes.
CL2015003031A1 (es) Compuesto peptídico
FR3006466B3 (fr) .
CL2016000680A1 (es) Formulaciones de anticuerpos anti-pdl1.
EP3023461A4 (en) SEALING COMPOSITION
DK2986726T3 (da) Hidtil ukendte bacillusstammesammensætninger
EP2889350A4 (en) ADHESIVE COMPOSITION
BR112016010220A2 (pt) compostos inibidores de autoxatina.
EP2989885A4 (en) HARVESTER
BR112015021295A2 (pt) composição de dois componentes.
HRP20181213T1 (hr) Peptidna smjesa
DK3027750T3 (da) Biokatalytisk sammensætning
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
FR3007636B1 (fr) Trocart perforant.
LT3030259T (lt) Peptidai
EP2999689A4 (en) Cyanoacrylate compositions
FR3001302B1 (fr) .
BR112016010562A2 (pt) composição antitranspirante.
EP2959776A4 (en) HERBICIDE COMPOSITION
KR20180085014A (ko) 펩티드 조성물
EP3060191C0 (en) A dispenser
FR3006896B1 (fr) Composition photoprotectrice
CL2016000836A1 (es) Composiciones de péptidos nuevas.
FR3001303B1 (fr) .